WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Dead whale in New Jersey had a fractured skull among numerous injuries, experts findThe O.J. Simpson case forced domestic violence into the spotlight, boosting a movementJPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024How major US stock indexes fared Friday, 4/12/2024Why don't humans have tails? A genetic mutation offers cluesClosing prices for crude oil, gold and other commoditiesIf you're retired or about to retire, think carefully about your tax strategyDead whale in New Jersey had a fractured skull among numerous injuries, experts findOdysseus moon lander sends new images in its last hoursJPMorgan Chase CEO warns about inflation, political polarization, wars